COPD Specialists in Washington
Links shared publicly online about this topic
COPD and Other Stuff » Blog Archive » The University of Washington Rocks!
pugetsoundblogs.com — “The University of Washington is a God send to us. I wrote the following in answer to a letter to the editor and decided to add it here as well. "The University of Washington 'elitist'? If 'elitist' means dedicated fine professors teaching a subject they they live their work.” View full resource at pugetsoundblogs.com
Most Recently Shared on June 16, 2010 at 5:48 pm By:
UW rocks, blogs patient: Thanks for all you do for us.. to make next generation lung patients fewer, living quality lives http://ow.ly/1Znuk
COPD Foundation Raises Awareness During COPD Week at ATS | Business Wire
businesswire.com — “The COPD Foundation and the American Thoracic Society (ATS) will host “COPD Week at the ATS” to bring awareness to Chronic Obstructive Pul” View full resource at businesswire.com
Most Recently Shared on November 10, 2011 at 3:24 pm By:
COPD Foundation Raises Awareness During COPD Week at ATS: WASHINGTON--(BUSINESS WIRE)--The COPD Foundation and t... http://t.co/LjoI1fKd
Medical News: FDA Okays New Indication for COPD Inhaler - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has expanded the approved indications for inhaled tiotropium bromide (Spiriva) to include reducing exacerbations of chronic obstructive pulmonary disease (COPD), in addition to i” View full resource at medpagetoday.com
Most Recently Shared on December 18, 2009 at 7:09 pm By:
FDA Okays New Indication for COPD Inhaler WASHINGTON (MedPage Today) -- The FDA has expanded the approved indications.. http://bit.ly/60RxSR
Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 5:28 pm By:
Medical News: FDA Okays COPD Maintenance Drug - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved the phosphodiesterase-4 inhibitor roflumilast (Daliresp) to prevent COPD exacerbations, despite a negative advisory panel vote last year.” View full resource at medpagetoday.com
Most Recently Shared on March 1, 2011 at 4:50 pm By:
Medpage Today: FDA Okays COPD Maintenance Drug http://bit.ly/hbVv4V Full http://bit.ly/emdYZW
Medical News: FDA Panel to Vote on Approval, Dosing for COPD Drug - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- An FDA advisory panel will vote Tuesday on whether a novel long-acting beta-adrenergic agonist is safe and effective at treating airflow obstruction in patients with chronic obstructive” View full resource at medpagetoday.com
Most Recently Shared on March 7, 2011 at 10:46 pm By:
FDA Panel to Vote on Approval, Dosing for COPD Drug http://bit.ly/eLAWdN
Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, th” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 10:11 pm By:
Medical News: FDA Panel to Vote on Approval, Dosing for COPD Drug - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- An FDA advisory panel will vote Tuesday on whether a novel long-acting beta-adrenergic agonist is safe and effective at treating airflow obstruction in patients with chronic obstructive” View full resource at medpagetoday.com
Most Recently Shared on March 8, 2011 at 3:07 pm By:
FDA advisory panel meets on Novartis' COPD drug indicatarol today. Key question centers on dosage in second review. http://bit.ly/eB0RXx
Medical News: New Inhaler Drug for COPD Approved - in Pulmonology, COPD from MedPage Today
medpagetoday.com — “WASHINGTON -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, th” View full resource at medpagetoday.com
Most Recently Shared on July 1, 2011 at 10:13 pm By:
Medpage Today: New Inhaler Drug for COPD Approved http://bit.ly/kTxsDs Full http://bit.ly/iZucPv
Pulmonary specialist seeks to raise awareness of COPD - MinotDailyNews.com | News, sports, business, jobs - Minot Daily News
minotdailynews.com — “Chronic Obstructive Pulmonary Disorder is a fatal disease that is highly preventable, according to Dr.” View full resource at minotdailynews.com
Most Recently Shared on November 18, 2010 at 8:15 pm By:
Pulmonary specialist seeks to raise awareness of COPD: Chronic Obstructive Pulmonary Disorder is a fatal disease... http://bit.ly/9J9ZNU
Low-dose Azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin COPD subjects - HODGE - Respirology - Wiley Online Library
onlinelibrary.wiley.com — “Low-dose Azithromycin improves phagocytosis of bacteria by both alveolar and monocyte-derived macrophagesin COPD subjects - HODGE - Respirology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 21, 2012 at 11:49 am By:
Long term use of low dose azithromycin as an attractive adjunct treatment option for COPD. http://t.co/7n2qaGUU
New Inhaler Drug for COPD Approved - QualityPoint Technologies
qualitypointtech.net — “WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol inhalation powder (Arcapta Neohaler), has won FDA approval as long-term maintenance therapy for chronic obstructive pulmonary disease, the agency announced.” View full resource at qualitypointtech.net
Most Recently Shared on July 1, 2011 at 11:00 pm By:
New Inhaler Drug for COPD Approved: WASHINGTON (MedPage Today) -- A new beta2-adrenergic agonist drug, indacaterol... http://bit.ly/iGWeAq
Health Professionals Training - American Lung Association
lungusa.org — “We offer may training opportunities thoughout the year including Asthma Educators Institute and COPD Educators Institute.” View full resource at lungusa.org
Most Recently Shared on November 17, 2010 at 7:35 pm By:
Today, @lungne is hosting the #COPD Symposium to educate health professionals in West Hartford, #CT http://bit.ly/aFjdym #WorldCOPDday
Ipratropium Bromide May Increase Risk For Cardiovascular Events
medicalnewstoday.com — “Patients taking ipratropium bromide, an anticholinergic used in the treatment of copd, may be at an increased risk for cardiovascular events (cve), including heart failure. researchers from the u” View full resource at medicalnewstoday.com
Most Recently Shared on January 7, 2010 at 11:12 am By:
Ipratropium Bromide May Increase Risk For Cardiovascular Events http://mnt.to/3vZh
UPDATE 2-US FDA staff focus on safety of Forest lung drug | Reuters
reuters.com — “* Drug worked to treat chronic lung disease-FDA staff* Uncertain signals about heart safety with drug* FDA advisory panel to review drug on ThursdayBy Anna YukhananovWASHINGTON, Feb 21 (Reuters) -” View full resource at reuters.com
Most Recently Shared on February 21, 2012 at 2:24 pm By:
RT @JohnCFierce: FDA regulators like Forest COPD drug's efficacy, but raise questions on cardio risks for the class. http://t.co/qxyBK25k
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
UW Medicine News
UWMed is Harborview, UW Med Ctr, UW Med Clinics, School of Medicine, Northwest Hospital & Med Ctr and Airlift Northwest
-
Lungs and Breathing
Organizing lung and breathing resources shared by health experts, advocates, and organizations into WisdomCards.
-
medical_tweets
Advertisement

